Original articlesShort-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria
References (21)
Whither short-course chemotherapy?
Br J Dis Chest
(1981)Short-course chemotherapy for pulmonary tuberculosis and some problems of its programme application with particular reference to India
Bull IUAT
(1985)La chimiothérapie de la tuberculose en 1983
Bull IUAT
(1983)- et al.
Comparaison de trois régimes de six mois dans la tuberculose pulmonaire en pratique de routine á Alger. Résultats au 19 mois
Rev Fr Mal Resp
(1983) - et al.
Enquête contrôlée comparant trois regimes de chimiothérapie quotidiens de six mois dans la tuberculose pulmonaire en pratique de routine a Alger
Rev Fr Mal Resp
(1985) Controlled clinical trial comparing a 6-month and l2-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara
Am Rev Respir Dis
(1984)Comparison of a 6-month chemotherapy regimen to a 12-month chemotherapy regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara
Bull IUAT
(1985)- et al.
Résultats d'un essai thérapeutique comparant un régime de 6 mois á un régime de 12 mois dans la tuberculose pulmonaire au Sahara algérian
Rev Fr Mal Resp
(1986) - et al.
Etude comparée de la coloration du bacille tuberculeux par la méthode en fluorescence dans I'examen des piéces d'exérèse pulmonaire
Arch Inst Pasteur D'Algérie
(1971) - et al.
Techniques et indications des examens bactériologiques en tuberculose.
(1968)
There are more references available in the full text version of this article.
Cited by (15)
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis
2017, The Lancet Infectious DiseasesCitation Excerpt :We added these newly identified articles to the 32 trials and ten cohorts identified for the previous review. The characteristics of the 33 trials7,12–43 and 19 cohort studies44–62 are summarised in the appendix. In seven of the cohort studies and 28 of the trials, data for patients with active drug-susceptible tuberculosis were also reported.
Surveillance of drug resistance for tuberculosis control: Why and how?
1995, Tubercle and Lung DiseaseDNA fingerprints of Mycobacterium tuberculosis do not change during the development of rifampicin resistance
1993, Tubercle and Lung DiseaseDrug combinations and the bioavailability of rifampicin
1990, TubercleEfficacy and safety of short-term chemotherapy for patients with spinal tuberculosis undergoing surgery in Chinese population: a meta-analysis
2021, Journal of Orthopaedic Surgery and ResearchTwenty years of rifampicin resistance surveillance in Bangladesh: Periodic vs. continuous monitoring
2018, International Journal of Tuberculosis and Lung Disease
Copyright © 1991 Published by Elsevier Ltd.